1Lunel F,Musset L.Mixed cyoglobulinemia and hepatitis C virus infection[J].Minerva Med,2001,92(1):35-42.
2Sene D,Ghillani-Dalbin P,Thibault V,et al.Longterm course of mixed cyoglobulinemia in patients infected with hepatitis C virus[J].Rheumatol,2004,31(11):2199-2206.
1[1]Stephanos JH.Nonhepatic manifestation and combined diseases in HCV infection[J].Dig Dis Sci,1996,41:63-74.
2[2]Gharagozloo S,Khoshnoodi J,Shokri F.Hepatitis C virus infection in patients with essential mixed cryoglobulinemia,multiple myeloma and chronic lymphocytic leukemia[J].Pathol Oncol Res,2001,7(2):135-139.
3[3]Luppi M,Grazia Ferrarri M,Bonaccorsi G,et al.Hepatitis C virus infection in subsets of neoplastic lmphoproliferations not associated with cryoglobulinemia[J].Leukemia,1996,10:351-355.
4[4]Ceare M,Frances F,Patrizia T,et al.Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy[J].Cancer,1996,7:2604-2613.
5[5]Zignego AL,Ferri C,Giannini C,et al.Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin′s lymphoma: evidence for a pathogenetic role[J].Arch Virol,1997,142:545-555.
7[7]Silvestri F,Pipan C, Barillari G,et al.Prevalence of hepatitis C virus infection in patients with lymphoprolife relative disorders[J].Blood,1996,84:4396-4401.
8Schwartz MM, Korbet SM, Lewis EJ. lmmunotactoid glomerulopathy. J Am Soc Nephrol, 2002, 13: 1390-1397.
9Monti G, Galli M, Invernizzi F, et al. Cryoglobulinaemias: a multi -center study of the early clinical and laboratory manifestations of primary and secondary disease. Q J Med,1995, 88: 115-126.
10Schwartz MM. The dysproteinemias and amyloidosis. In:Jennetteet JC, Olson JL, Schwartz MM, et al. eds. Heptinstall's pathology of the kidney. Philadelphia:Lippincott-Raven, 1998.1354-1361.
10Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia : demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum ,2004,33:355-374.
